Discovery Laboratories has entered into a definitive agreement with Lacey Manufacturing, a unit of Precision Engineered Products, to manufacture and supply product for the commercial launch of Afectair. Discovery Labs anticipates that the drug will be commercially available in late 2012. “This manufacturing and supply agreement with Lacey is an important operational milestone that takes us one step closer to the commercial introduction of Afectair later this year,” said Thomas F. Mi...